Innovative laparoscopic surgical device offers technical and clinical improvement to #1 bariatric surgical procedure
Cincinnati, Ohio – August 3, 2017 – Standard Bariatrics, Inc., an innovator of bariatric surgical devices, has received U.S. Food and Drug Administration (FDA) clearance for the STANDARD CLAMP™. The first-of-its-kind, disposable laparoscopic surgical clamp can assist surgeons performing laparoscopic sleeve gastrectomy, the most common and effective weight loss surgery. The company has begun commercial distribution of the product in the United States. Read More
CincyTech announced on Monday the first three firms that will receive seed money from its latest investment fund.
Navistone, a data-driven marketing firm, and two health firms, ReadySet Surgical and Standard Bariatrics, will get funding from the Over-the-Rhine-based accelerator’s $30.1 million Fund IV, which closed in April. The fund is targeting to invest in 25 Southwest Ohio startups in the digital and life sciences fields that CincyTech officials say will create 600 new jobs in the next half decade.
Click link below for the full story:
Standard Bariatrics, a Blue Ash startup founded by Dr. Jon Thompson of UC Health, has secured a $500,000 investment from the Dayton Development Coalition.
Thompson invented a medical stapler that could change how weight-loss surgery is performed, and the investment from the coalition’s Accelerant Fund I seed-stage venture fund will bring the total raised by Standard Bariatrics to more than $1.5 million by the end of this year.
To read the full story, click the link below:
Cincinnati Children’s Hospital Medical Center announced today that it will invest $6 million to create startup companies based on technology developed by its researchers.
The hospital, based in Avondale, found out last week that it will receive $3 million in funding from Ohio’s Third Frontier economic development initiative, and Cincinnati Children’s intends to match that three-year grant with $3 million of its own to create the Tomorrow Fund III. Read More